Chrysin-induced apoptosis is mediated through p38 and Bax activation in B16-F1 and A375 melanoma cells

International Journal of Oncology

Volumn 38, Issue 2, 2011, Pages 473-483

  Pichichero, Elena ^a   Cicconi, Rosella ^b   Mattei, Maurizio ^b   Canini, Antonella ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Centro di Servizi Interdipartimentale Stazione Per la Tecnologia Animale   (Italy)

Author keywords

A375; Apoptosis; B16 F1; Bax; Chrysin; MAP kinases; Protoporphyrine IX; SB 203580

Indexed keywords

CASPASE 3; CHRYSIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PORPHOBILINOGEN DEAMINASE; PROTEIN BAX; PROTOPORPHYRIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASES; ENZYME ACTIVATION; FLAVONOIDS; HUMANS; MELANOMA; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 78651249051     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2010.876     Document Type: Article

References (53)

1. Ren W, Qiao Z, Wang H, Zhu L and Zhang L: Flavonoids: promising anticancer agents. Med Res Rev 23: 519-534, 2003.
2. Ko HH, Tsao LT, Yu KL, Liu CT, Wang JP and Lin CN: Structure-activity relationship studies on chalcone derivatives. the potent inhibition of chemical mediators release. Bioorg Med Chem 11: 105-111, 2003.
3. Williams RJ, Spencer JPE and Rice-Evans C: Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36: 838-849, 2004.
4. Soobratte MA, Neergheen VS, Luximon-Ramma A, Aruoma OI and Bahorun T: Phenolics as potential antioxidant therapeutic agents: mechanism of action. Mutat Res 579: 200-213, 2005.
5. Cho H, Yun CW, Park WK, Kong JY, Kin KS, Park Y, Lee S and Kim BK: Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharmacol Res 49: 37-43, 2004.
6. Lapidot T, Walker MD and Kanner J: Antioxidant and prooxidant effects of phenolics on pancreatic beta-cells in vitro. J Agric Food Chem 50: 7220-7225, 2002.
7. Weng MS, Ho YS and Lin JK: Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogenactivated protein kinase. Biochem Pharmacol 69: 1815-1827, 2005.
8. Pichichero E, Cicconi R, Mattei M, Gallinella-Muzi M and Canini A: Acacia honey and chrysin reduces proliferation of melanoma cells through alteration in cell cycle progression. Int J Oncol 37: 973-981, 2010.
9. Zhang T, Chen X, Qu L, Wu J, Cui R and Zhao Y: Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg Med Chem 12: 6097-6105, 2004.
10. Woo KJ, Jeong YJ, Park JW and Kwon TK: Chrysin induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochem Biophys Res Commun 325: 1215-1222, 2004.
11. Norbury CJ and Hickson ID: Cellular response to DNA damage. Annu Rev Pharmacol Toxicol 41: 367-401, 2001.
12. Hotchkiss RS, Strasser A, McDunn JE and Swanson PE: Mechanism disease - cell death. N Engl J Med 361: 1570-1583, 2009.
13. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvoge L and Kroemer G: Cell death modalities: classification and pathophysiological implications. Cell Death Differ 14: 1237-1266, 2007.
14. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
15. Cory S and Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002.
16. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ and Cheng EHY: Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348-1358, 2006.
17. Fan TJ, Han LH, Cong RS and Liang J: Caspase family proteases and apoptosis. Acta Biochim Biophys Sin 37: 719-727, 2005.
18. Leszczyniecka M, Roberts T, Dent P, Grant S and Fisher PB: Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther 90: 105-156, 2001.
19. Horbinski C and Chu CT: Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic Biol Med 38: 2-11, 2005.
20. Chuang SM, Wang IC and Yang JL: Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis 21: 1423-1432, 2000.
21. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
22. Ickowicz Schwartz DI, Gozlan Y, Greenbaum L, Babushkina T, Katcoff DJ and Malik Z: Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma. Br J Cancer 90: 1833-1841, 2004.
23. Hinnen P, de Rooij FWM, van Velthuysen MLF, Edixhoven A, van Hillegersberg R, Tilanus HW, Wilson JHP and Siersemal PD: Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study patients with (pre) malignant lesion of oesophagus. Br J Cancer 78: 679-682, 1998.
24. Spencer JPE, Abd El Mhosen MM and Rice-Evans C: Cellular uptake and metabolism of flavonoids and their metabolites: implication for their bioactivity. Arch Biochem Biophys 423: 148-161, 2004.
25. Depeint F, Gee JM, Williamson G and Johnson IT: Evidence for consistent patterns between flavonoid structures and cellular activities. Proc Nutr Soc 61: 97-103, 2002.
26. Mukai R, Shirai Y and Saito N: Subcellular localization of flavonol aglycone in hepatocytes visualized by confocal laser scanning fluorescence microscope. Cytotechnology 59: 177-182, 2009.
27. Walgren RA, Walle UK and Walle T: Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem Pharmacol 55: 1721-1727, 1998.
28. Zhanag S, Qin C and Safe SH: Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effect of structure and cell context. Environ Health Perspect 11: 1877-1882, 2003.
29. Hodek P, Trefil P and Stiborova M: Flavonoids - potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 139: 1-21, 2002.
30. Alesiani D, Cicconi R, Mattei M, Montesano C, Bei R and Canini A: Cell cycle arrest and differentiation induction by 5,7-dimethoxycoumarin in melanoma cell lines. Int J Oncol 32: 425-434, 2009.
31. Vena FCB, Turchiello RF, Laville I, Pigaglio S, Blais J and Tedesco AC: 5-aminolavulinic acid ester-induced protoporphirin IX in a murine melanoma cell line. Lasers Med Sci 19: 119-126, 2004.
32. Ortel B, Sharlin D, O'Donnell D, Sinha AK, Maytin EV and Hasan T: Differentiation enhances aminolevulinic acid-dependent photodinamic treatment of LNCaP prostate cancer cells. Br J Cancer 87: 1321-1327, 2002.
33. Alesiani D, Cicconi R, Mattei M, Bei R and Canini A: Inhibition of Mek 1/2 kinase activity and stimulation of melanogenesis by 5,7-dimethoxycoumarin. Int J Oncol 34: 1727-1735, 2008.
34. Sato N, Moore BW, Keevey S, Drazba JA, Hasan T and Maytin EV: Vitamin D enhances ALA-induced protoporphyrin IX production and photodynamic cell death in 3-D organotypic cultures of keratinocytes. J Investig Dermatol 127: 925-934, 2007.
35. Siboni G, Amit-Patito I, Weizman E, Waintraub-Porat M, Weitman H, Ehrenberg B and Malik Z: Specificity of photosensitizer accumulation in undifferentiated versus differentiated colon carcinoma cells. Cancer Lett 196: 57-64, 2003.
36. Sinha AK, Anand S, Ortel BJ, Chang Y, Mai Z, Hasan T and Maytin EV: Methotrexate used in combination with amino-laevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 95: 485-495, 2006.
37. Sassa S: Regulation of the genes for the heme pathway enzymes in erythroid and non-erythroid cells. Int J Cell Cloning 8: 10-26, 1990.
38. Greenbaum L, Katcoff DJ, Dou H, Gozlan Y and Malik Z: A porphobilinogen deaminase (PBGD) Ran-binding protein interaction is implicated in nuclear trafficking of PBGD in differentiating glioma cells. Oncogene 22: 5221-5228, 2003.
39. MacDonald IJ and Dougherty TJ: Basic principles of photodynamic therapy. J Porphyr Phthalocya 5: 105-129, 2001.
40. Pandey RK: Recent advances inphotodynamic therapy. J Porphyr Phthalocyanines 4: 368-373, 2000.
41. Namkoong J, Martino JJ and Chen S: From existing therapies to novel targets: a current view on melanoma. Front Biosci 11: 2081-2092, 2006.
42. Panka DJ, Atkins MB and Mier JW: Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma. Clin Cancer Res 12: 2371-2375, 2006.
43. Fueller J, Becker M, Sienerth AR, Fischer A, Hotz C and Galmiche A: C-RAF activation promotes BAD poly-ubiquitylation and turn-over by the proteasome. Biochem Biophys Res Commun 370: 552-556, 2008.
44. Enslen H, Brancho DM and Davis RJ: Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J 19: 1301-1311, 2000.
45. Zarubin T and Han J: Activation and signaling of the p38 MAP kinase pathway. Cell Res 15: 11-18, 2005.
46. Hata K, Hori K and Takahashi S: Role of p38 MAPK in Lupeol-induced B16 2F2 mouse melanoma cell differentiation. J Biochem 134: 441-445, 2003.
47. Ivanov VN and Ronai Z: p38 protects human melanoma cells from UV induced apoptosis through down-regulation of NFkappaB activity and Fas expression. Oncogene 19: 3003-3012, 2000.
48. Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, Ten Dijke P, Heldin CH and Landstrom M: Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 14: 529-544, 2003.
49. Van Leathem A, Van Kelst S, Lippens S, Declercq W, Vandenabeele P, Janssens S, Vandenheede JR, Garmyn M and Agostinis P: Activation of p38 MAPK is required for Bax translocation to mitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes. FASEB J 18: 1946-1948, 2004.
50. Sheng G, Guo J and Warner BW: Epidermal growth factor receptor signaling modulates apoptosis via p38alpha MAPK-dependent activation of Bax in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 293: G599-G606, 2007.
51. Jang BC, Lim KJ, Paik JH, Cho JW, Baek WK, Suh MH, Park JB, Kwon TK, Park JW, Kim SP, Shin DH, Song D, Bae JH, Mun KC and Suh SI: Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-d in U937 cells. Biochem Pharmacol 67: 1819-1829, 2004.
52. Gross A, McDonnell JM and Korsmeyer SJ: Bcl-2 family members and the mitochondrial in apoptosis. Genes Dev 13: 1899-1911, 1999.
53. Porter AG and Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104, 1999.